MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 244 filers reported holding MYRIAD GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $926,000 | -6.4% | 34,000 | -1.6% | 0.08% | -4.5% |
| Q3 2019 | $989,000 | +3.0% | 34,550 | 0.0% | 0.09% | +4.7% |
| Q2 2019 | $960,000 | -18.2% | 34,550 | -2.3% | 0.08% | -17.5% |
| Q1 2019 | $1,174,000 | +8.1% | 35,350 | -5.4% | 0.10% | -3.7% |
| Q4 2018 | $1,086,000 | -36.6% | 37,350 | +0.3% | 0.11% | -21.9% |
| Q3 2018 | $1,714,000 | +23.1% | 37,250 | 0.0% | 0.14% | +16.1% |
| Q2 2018 | $1,392,000 | +15.6% | 37,250 | -8.6% | 0.12% | +25.5% |
| Q1 2018 | $1,204,000 | -17.0% | 40,750 | -3.6% | 0.09% | -13.0% |
| Q4 2017 | $1,451,000 | -6.0% | 42,250 | -0.9% | 0.11% | -10.0% |
| Q3 2017 | $1,543,000 | +99.1% | 42,650 | +42.2% | 0.12% | +93.5% |
| Q2 2017 | $775,000 | +35.0% | 30,000 | +0.3% | 0.06% | +34.8% |
| Q1 2017 | $574,000 | +14.3% | 29,900 | -0.7% | 0.05% | +21.1% |
| Q4 2016 | $502,000 | +0.8% | 30,100 | +24.4% | 0.04% | +18.8% |
| Q3 2016 | $498,000 | -40.1% | 24,200 | -11.0% | 0.03% | -11.1% |
| Q2 2016 | $832,000 | -61.4% | 27,200 | -52.8% | 0.04% | -54.4% |
| Q1 2016 | $2,158,000 | -59.3% | 57,645 | -53.1% | 0.08% | -53.3% |
| Q4 2015 | $5,307,000 | +15.2% | 122,958 | +0.3% | 0.17% | +12.7% |
| Q3 2015 | $4,605,000 | +7.1% | 122,578 | -3.1% | 0.15% | +26.1% |
| Q2 2015 | $4,299,000 | -8.6% | 126,468 | -4.8% | 0.12% | -3.3% |
| Q1 2015 | $4,705,000 | -8.3% | 132,898 | -11.8% | 0.12% | -0.8% |
| Q4 2014 | $5,133,000 | -37.4% | 150,718 | -29.1% | 0.12% | -34.0% |
| Q3 2014 | $8,201,000 | -14.5% | 212,630 | -14.3% | 0.19% | -7.8% |
| Q2 2014 | $9,592,000 | +3.0% | 248,000 | -9.0% | 0.20% | +1.5% |
| Q1 2014 | $9,313,000 | -48.9% | 272,390 | -68.6% | 0.20% | -43.5% |
| Q4 2013 | $18,213,000 | -13.5% | 868,090 | -3.2% | 0.36% | -0.6% |
| Q3 2013 | $21,064,000 | -18.2% | 896,330 | -6.4% | 0.36% | -18.3% |
| Q2 2013 | $25,737,000 | – | 957,830 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |